Implantation Test – Biocompatibility Assessment according to EN ISO 10993-6
One of the most critical phases in the development of medical devices is the assessment of their compatibility with human health. Particularly for long-term and permanent implants, the potential effects of these devices on the human body must be evaluated. This is where implantation tests, which must be conducted according to EN ISO 10993-6, become essential. These tests enable the early detection of potential bodily reactions to implant materials. The objective is to ensure both patient safety and regulatory compliance.
What is an Implantation Test for Medical Devices?
Medical devices must be safe and compatible when they come into contact with the human body. Biocompatibility assessments for long-term or permanent implants are conducted through implantation tests within the scope of EN ISO 10993-6. The implantation test serves to observe the local effects that a product or material may have on living tissue. This allows for the early detection of potential inflammations, necroses, fibroses, or foreign body reactions.
The EN ISO 10993-6 Standard in Detail
This standard aims to measure tissue reaction, assess local biocompatibility risks, and confirm safe use for medical devices. It is used to describe in detail how tests should be performed for both subcutaneous (under the skin) and intramuscular applications.
In Which Areas Are Implantation Tests Applied?
Implantation tests are important for the following types of medical devices:
- Orthopedic Implants (plates, screws, prostheses)
- Cardiovascular Devices (stents, artificial heart valves)
- Dental Implants
- Wound Closure Materials (sutures, biomaterials)
- Medical Materials with Long-Term Contact
How is the Test Process Conducted?
Typical Procedure for Implantation Tests according to EN ISO 10993-6:
- Preparation of the Test Sample – Sterilized devices or materials are used.
- Selection of the Animal Model – Typically, rabbits or rodents are preferred.
- Surgical Implantation – The sample is implanted into the tissue.
- Observation Period – Short-term (weeks) and long-term (months) evaluations are conducted.
- Histopathological Examination – Tissue samples are examined under a microscope.
- Reporting – Parameters such as inflammation, fibrosis, and degeneration are assessed.
Why is the implantation test important?
- It ensures patient safety.
- It ensures regulatory compliance (MDR, FDA, etc.).
- It is a fundamental step for product approval.
- It demonstrates the preclinical reliability of new biomaterials.
What does Nano-Test do?
Test and control processes are defined according to the manufacturer's requirements and product structure. We will create a roadmap for you and report on the conformity of your medical devices with the relevant standards and legal regulations. EN ISO 10993-6 standard, implantation testing, and all your questions – contact us!